BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 29371957)

  • 1. Anti-Müllerian hormone levels in patients with gestational trophoblastic neoplasia treated with different chemotherapy regimens: a prospective cohort study.
    Bi X; Zhang J; Cao D; Sun H; Feng F; Wan X; Xiang Y; Qiu L; Cheng X; Yang J; Shen K
    Oncotarget; 2017 Dec; 8(69):113920-113927. PubMed ID: 29371957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective cohort study with serum anti-mullerian hormone levels change in patients undergoing uterine preservation after gestational trophoblastic neoplasia treatment with a methotrexate regimen.
    Tuan Dat D; Huyen Thuong PT; Hong Hai D; Khac Toan N; Tai Duc N; Duy Anh N; Thi Thu Ha N
    Clin Ter; 2024; 175(2):128-134. PubMed ID: 38571471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-Müllerian hormone as a marker of ovarian reserve following chemotherapy in patients with gestational trophoblastic neoplasia.
    Iwase A; Sugita A; Hirokawa W; Goto M; Yamamoto E; Takikawa S; Nakahara T; Nakamura T; Kondo M; Kikkawa F
    Eur J Obstet Gynecol Reprod Biol; 2013 Apr; 167(2):194-8. PubMed ID: 23274042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effects of Chemotherapy on the Levels of Serum Anti-Müllerian Hormone in Patients with Gestational Trophoblastic Neoplasia.
    Zamani M; Mohsenpour F; Torkzaban F; Atrvash N; Majlesi A; Torkzaban A
    J Reprod Infertil; 2023; 24(1):43-48. PubMed ID: 36919051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal study of AMH variations in 122 Adolescents and Young Adults (AYA) and non-AYA lymphoma patients to evaluate the chemo-induced ovarian toxicity to further personalise fertility preservation counselling.
    Decanter C; Delepine J; Behal H; Manier S; Bruno B; Barbatti M; Robin C; Labreuche J; Morschhauser F; Pigny P
    Hum Reprod; 2021 Sep; 36(10):2743-2752. PubMed ID: 34417822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective evaluation of serum anti-Müllerian hormone dynamics in 250 women of reproductive age treated with chemotherapy for breast cancer.
    Dezellus A; Barriere P; Campone M; Lemanski C; Vanlemmens L; Mignot L; Delozier T; Levy C; Bendavid C; Debled M; Bachelot T; Jouannaud C; Loustalot C; Mouret-Reynier MA; Gallais-Umbert A; Masson D; Freour T
    Eur J Cancer; 2017 Jul; 79():72-80. PubMed ID: 28463758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-Müllerian Hormone in Patients Treated with Chemotherapy for Gestational Trophoblastic Neoplasia Does Not Predict Short-Term Fertility.
    Ghorani E; Ramaswami R; Smith RJ; Savage PM; Seckl MJ
    J Reprod Med; 2016; 61(5-6):205-9. PubMed ID: 27424359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oocyte matched follicular fluid anti-Müllerian hormone is an excellent predictor of live birth after fresh single embryo transfer.
    Ciepiela P; Dulęba AJ; Kario A; Chełstowski K; Branecka-Woźniak D; Kurzawa R
    Hum Reprod; 2019 Nov; 34(11):2244-2253. PubMed ID: 31725884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The correlations of anti-mullerian hormone, follicle-stimulating hormone and antral follicle count in different age groups of infertile women.
    Barbakadze L; Kristesashvili J; Khonelidze N; Tsagareishvili G
    Int J Fertil Steril; 2015; 8(4):393-8. PubMed ID: 25780521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the multiples of the median of serum anti-müllerian hormone and pregnancy outcomes in patients with gestational trophoblastic disease: A case-control study.
    Lai THT; Lau LSK; Ngu SF; Chu MYM; Chan KKL; Ng EHY; Ngan HYS; Li RHW; Tse KY
    Cancer Med; 2024 Apr; 13(7):e7134. PubMed ID: 38545760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of actinomycin D on ovarian reserve in low-risk gestational trophoblastic neoplasia.
    Xue W; Cang W; Zhao J; Feng F; Wan X; Ren T; Qiu L; Yang J; Xiang Y
    Int J Gynecol Cancer; 2023 Aug; 33(8):1222-1226. PubMed ID: 37290904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Radioactive Iodine Therapy on Ovarian Reserve: A Prospective Pilot Study.
    Evranos B; Faki S; Polat SB; Bestepe N; Ersoy R; Cakir B
    Thyroid; 2018 Dec; 28(12):1702-1707. PubMed ID: 30156472
    [No Abstract]   [Full Text] [Related]  

  • 13. Prediction of ovarian function recovery in young breast cancer patients after protection with gonadotropin-releasing hormone agonist during chemotherapy.
    Lee DY; Park YH; Lee JE; Choi D
    Breast Cancer Res Treat; 2018 Oct; 171(3):649-656. PubMed ID: 29943121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-Müllerian hormone serum values and ovarian reserve: can it predict a decrease in fertility after ovarian stimulation by ART cycles?
    Patrelli TS; Gizzo S; Sianesi N; Levati L; Pezzuto A; Ferrari B; Bacchi Modena A
    PLoS One; 2012; 7(9):e44571. PubMed ID: 22984527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing the effect of laparoscopic supracervical and total hysterectomy for uterine fibroids on ovarian reserve by assessing serum anti-mullerian hormone levels: a prospective cohort study.
    Yuan H; Wang C; Wang D; Wang Y
    J Minim Invasive Gynecol; 2015; 22(4):637-41. PubMed ID: 25653041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infertile women below the age of 40 have similar anti-Müllerian hormone levels and antral follicle count compared with women of the same age with no history of infertility.
    Hvidman HW; Bentzen JG; Thuesen LL; Lauritsen MP; Forman JL; Loft A; Pinborg A; Nyboe Andersen A
    Hum Reprod; 2016 May; 31(5):1034-45. PubMed ID: 26965431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-specific serum anti-mullerian hormone and follicle stimulating hormone concentrations in infertile Iranian women.
    Raeissi A; Torki A; Moradi A; Mousavipoor SM; Pirani MD
    Int J Fertil Steril; 2015; 9(1):27-32. PubMed ID: 25918589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Impact of chemotherapy on ovarian function and quality of life of patients with gestational trophoblastic neoplasia].
    Xue W; Yang JJ; Zhao J; Ren T; Feng FZ; Wan XR; Xiang Y
    Zhonghua Fu Chan Ke Za Zhi; 2018 Jun; 53(6):377-383. PubMed ID: 29961279
    [No Abstract]   [Full Text] [Related]  

  • 19. Reduced ovarian reserve in young early breast cancer patients: preliminary data from a prospective cohort trial.
    Wenners A; Grambach J; Koss J; Maass N; Jonat W; Schmutzler A; Mundhenke C
    BMC Cancer; 2017 Sep; 17(1):632. PubMed ID: 28877720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effect of goserelin on ovarian reserve during (neo)adjuvant chemotherapy in young breast cancer patients: a prospective cohort study in China.
    Wang S; Pei L; Hu T; Jia M; Wang S
    Hum Reprod; 2021 Mar; 36(4):976-986. PubMed ID: 33411897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.